FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 469, 481-489
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Jiangsu Province
- Nanjing Institute of Technology
This publication has 40 references indexed in Scilit:
- Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK/mTOR pathway in prostate cancerOncology Reports, 2015
- Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer - a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activationOncotarget, 2015
- Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistanceOncogene, 2015
- RETRACTED ARTICLE: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagyBritish Journal of Cancer, 2015
- Insights into Chemoresistance of Prostate CancerInternational Journal of Biological Sciences, 2015
- Autophagy as a modulator and target in prostate cancerNature Reviews Urology, 2014
- An Overview of Autophagy: Morphology, Mechanism, and RegulationAntioxidants & Redox Signaling, 2014
- Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxelJournal of Translational Medicine, 2013
- Characterisation and manipulation of docetaxel resistant prostate cancer cell linesMolecular Cancer, 2011
- Atg8, a Ubiquitin-like Protein Required for Autophagosome Formation, Mediates Membrane Tethering and HemifusionCell, 2007